John B Jemmott1, Loretta S Jemmott, Ann O'Leary, Zolani Ngwane, Larry D Icard, G Anita Heeren, Xoliswa Mtose, Craig Carty. 1. John B. Jemmott III, G. Anita Heeren, and Craig Carty are with the Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia. John B. Jemmott III is also with the Annenberg School for Communication, University of Pennsylvania. Loretta S. Jemmott is with the School of Nursing, University of Pennsylvania. Ann O'Leary is with the Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Zolani Ngwane is with the Department of Anthropology, Haverford College, Haverford, PA. Larry D. Icard is with the College of Health Professionals and Social Work, Temple University, Philadelphia, PA. Xoliswa Mtose is with the Faculty of Education, University of Fort Hare, East London, South Africa.
Abstract
OBJECTIVES: We tested the efficacy of a sexual risk-reduction intervention for men in South Africa, where heterosexual exposure is the main mode of HIV transmission. METHODS:Matched-pairs of neighborhoods in Eastern Cape Province, South Africa, were randomly selected and within pairs randomized to 1 of 2 interventions based on social cognitive theory and qualitative research: HIV/sexually transmitted infection (STI) risk-reduction, targeting condom use, or attention-matched control, targeting health issues unrelated to sexual risks. Sexually active men aged 18 to 45 years were eligible. The primary outcome was consistent condom use in the past 3 months. RESULTS:Of 1181 participants, 1106 (93.6%) completed the 12-month follow-up. HIV and STI risk-reduction participants had higher odds of reporting consistent condom use (odds ratio [OR] = 1.32; 95% confidence interval [CI] = 1.03, 1.71) and condom use at last vaginal intercourse (OR = 1.40; 95% CI = 1.08, 1.82) than did attention-control participants, adjusting for baseline prevalence. No differences were observed on unprotected intercourse or multiple partnerships. Findings did not differ for sex with steady as opposed to casual partners. CONCLUSIONS: Behavioral interventions specifically targeting men can contribute to efforts to reduce sexual risk behaviors in South Africa.
RCT Entities:
OBJECTIVES: We tested the efficacy of a sexual risk-reduction intervention for men in South Africa, where heterosexual exposure is the main mode of HIV transmission. METHODS: Matched-pairs of neighborhoods in Eastern Cape Province, South Africa, were randomly selected and within pairs randomized to 1 of 2 interventions based on social cognitive theory and qualitative research: HIV/sexually transmitted infection (STI) risk-reduction, targeting condom use, or attention-matched control, targeting health issues unrelated to sexual risks. Sexually active men aged 18 to 45 years were eligible. The primary outcome was consistent condom use in the past 3 months. RESULTS: Of 1181 participants, 1106 (93.6%) completed the 12-month follow-up. HIV and STI risk-reduction participants had higher odds of reporting consistent condom use (odds ratio [OR] = 1.32; 95% confidence interval [CI] = 1.03, 1.71) and condom use at last vaginal intercourse (OR = 1.40; 95% CI = 1.08, 1.82) than did attention-control participants, adjusting for baseline prevalence. No differences were observed on unprotected intercourse or multiple partnerships. Findings did not differ for sex with steady as opposed to casual partners. CONCLUSIONS: Behavioral interventions specifically targeting men can contribute to efforts to reduce sexual risk behaviors in South Africa.
Authors: Milton L Wainberg; M Alfredo González; Karen McKinnon; Katherine S Elkington; Diana Pinto; Claudio Gruber Mann; Paulo E Mattos Journal: Soc Sci Med Date: 2007-05-01 Impact factor: 4.634
Authors: Richard Crosby; Ralph J DiClemente; Richard Charnigo; Gregory Snow; Adewale Troutman Journal: Am J Public Health Date: 2009-02-12 Impact factor: 9.308
Authors: Blair T Johnson; Lori A J Scott-Sheldon; Natalie D Smoak; Jessica M Lacroix; John R Anderson; Michael P Carey Journal: J Acquir Immune Defic Syndr Date: 2009-08-01 Impact factor: 3.731
Authors: John B Jemmott; Alisa Stephens-Shields; Ann O'Leary; Loretta Sweet Jemmott; Anne Teitelman; Zolani Ngwane; Xoliswa Mtose Journal: Prev Med Date: 2015-01-04 Impact factor: 4.018
Authors: Anne M Teitelman; Scarlett L Bellamy; John B Jemmott; Larry Icard; Ann O'Leary; Samira Ali; Zolani Ngwane; Monde Makiwane Journal: Ann Behav Med Date: 2017-04
Authors: John B Jemmott; Loretta S Jemmott; Zolani Ngwane; Jingwen Zhang; G Anita Heeren; Larry D Icard; Ann O'Leary; Xoliswa Mtose; Anne Teitelman; Craig Carty Journal: Prev Med Date: 2014-04-13 Impact factor: 4.018
Authors: John B Jemmott; Loretta Sweet Jemmott; Ann O'Leary; Larry D Icard; Scott E Rutledge; Robin Stevens; Janet Hsu; Alisa J Stephens Journal: AIDS Behav Date: 2015-07
Authors: Branwen N Owen; Jocelyn Elmes; Romain Silhol; Que Dang; Ian McGowan; Barbara Shacklett; Edith M Swann; Ariane van der Straten; Rebecca F Baggaley; Marie-Claude Boily Journal: J Int AIDS Soc Date: 2017-01-12 Impact factor: 5.396